CVS Group (LON:CVSG) Given “Outperform” Rating at Royal Bank Of Canada

CVS Group (LON:CVSG)‘s stock had its “outperform” rating reaffirmed by Royal Bank Of Canada in a report issued on Thursday, Marketbeat.com reports. They presently have a GBX 1,900 target price on the stock. Royal Bank Of Canada’s price target indicates a potential upside of 48.67% from the company’s current price.

Other analysts have also recently issued reports about the stock. Berenberg Bank restated a “buy” rating and set a GBX 2,000 target price on shares of CVS Group in a research report on Tuesday, November 18th. Peel Hunt restated a “buy” rating and set a GBX 1,600 price objective on shares of CVS Group in a research report on Tuesday, November 18th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of GBX 1,724.

CVS Group Stock Performance

CVS Group stock traded down GBX 16 during midday trading on Thursday, hitting GBX 1,278. The stock had a trading volume of 273,313 shares, compared to its average volume of 1,049,178. CVS Group has a 52-week low of GBX 885 and a 52-week high of GBX 1,648. The company has a market capitalization of £896.59 million, a PE ratio of 17.36, a P/E/G ratio of 1.77 and a beta of 1.31. The firm’s fifty day moving average is GBX 1,338.78 and its two-hundred day moving average is GBX 1,282.95. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 121.52.

CVS Group (LON:CVSG) last released its quarterly earnings data on Thursday, February 26th. The company reported GBX 40.20 earnings per share (EPS) for the quarter. CVS Group had a net margin of 2.31% and a return on equity of 5.35%. On average, research analysts forecast that CVS Group will post 93.9393939 EPS for the current year.

Insider Activity

In related news, insider Richard Gray acquired 2,000 shares of the stock in a transaction on Monday, January 5th. The stock was bought at an average cost of £1,276.96 per share, with a total value of £2,553,920. Also, insider Paul Higgs purchased 1,235 shares of the stock in a transaction that occurred on Friday, December 5th. The stock was purchased at an average price of GBX 1,214 per share, with a total value of £14,992.90. Over the last ninety days, insiders purchased 4,060 shares of company stock valued at $257,890,365. 1.42% of the stock is currently owned by company insiders.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.